PUBLIC LAW 106–310—OCT. 17, 2000
Public Law 106–310 106th Congress
Children’s Health Act
The Children’s Health Act of 2000 (Pub.L. 106–310, 114 Stat. 1101, enacted October 17, 2000), signed by President Clinton on October 17, 2000, was brought into law to conduct a study focusing on children from before conception to 21 years of age.
The law authorized the formation of federal child health funding programs and included a pediatric research initiative in the National Institutes of Health.
The focus of this Act was to increase research and treatment of numerous health issues concerning children including autism, asthma, epilepsy, and oral health to name a few. Since it was implemented into law, the Children’s Health Act has brought upon numerous programs. Some highlights of the Act include:
- The Children’s Day Care Health and Safety Act
- The Safe Schools/Health Students Initiative
- The Healthy Start Program
- Efforts to ensure safe and quality mental health treatment
DIVISION A—CHILDREN’S HEALTH
Sec. 101. Expansion, intensification, and coordination of activities of National Insti- tutes of Health with respect to research on autism.
Sec. 102. Developmental disabilities surveillance and research programs.
Sec. 103. Information and education.
Sec. 104. Inter-agency Autism Coordinating Committee.
Sec. 105. Report to Congress.
DIVISION A—CHILDREN’S HEALTH
SEC. 101. EXPANSION, INTENSIFICATION, AND COORDINATION OF ACTIVITIES OF NATIONAL INSTITUTES OF HEALTH WITH RESPECT TO RESEARCH ON AUTISM.
Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding at the end the following section:
‘‘EXPANSION, INTENSIFICATION, AND COORDINATION OF ACTIVITIES OF NATIONAL INSTITUTES OF HEALTH WITH RESPECT TO RESEARCH ON AUTISM
‘‘SEC. 409C. (a) IN GENERAL.—
‘‘(1) EXPANSION OF ACTIVITIES.—The Director of NIH (in
this section referred to as the ‘Director’) shall expand, intensify, and coordinate the activities of the National Institutes of Health with respect to research on autism.
‘‘(2) ADMINISTRATION OF PROGRAM; COLLABORATION AMONG AGENCIES.—The Director shall carry out this section acting through the Director of the National Institute of Mental Health and in collaboration with any other agencies that the Director determines appropriate.
‘‘(b) CENTERS OF EXCELLENCE.—
‘‘(1) IN GENERAL.—The Director shall under subsection
(a)(1) make awards of grants and contracts to public or non- profit private entities to pay all or part of the cost of planning, establishing, improving, and providing basic operating support for centers of excellence regarding research on autism.
‘‘(2) RESEARCH.—Each center under paragraph (1) shall conduct basic and clinical research into autism. Such research should include investigations into the cause, diagnosis, early detection, prevention, control, and treatment of autism. The centers, as a group, shall conduct research including the fields of developmental neurobiology, genetics, and psychopharmacology.
‘‘(3) SERVICES FOR PATIENTS.—
‘‘(A) IN GENERAL.—A center under paragraph (1) may
expend amounts provided under such paragraph to carry out a program to make individuals aware of opportunities to participate as subjects in research conducted by the centers.
‘‘(B) REFERRALS AND COSTS.—A program under subparagraph (A) may, in accordance with such criteria as the Director may establish, provide to the subjects described in such subparagraph, referrals for health and other services, and such patient care costs as are required for research.
‘‘(C) AVAILABILITY AND ACCESS.—The extent to which a center can demonstrate availability and access to clinical services shall be considered by the Director in decisions about awarding grants to applicants which meet the sci- entific criteria for funding under this section.
‘‘(4) COORDINATION OF CENTERS; REPORTS.—The Director
shall, as appropriate, provide for the coordination of information among centers under paragraph (1) and ensure regular commu- nication between such centers, and may require the periodic preparation of reports on the activities of the centers and the submission of the reports to the Director.
‘‘(5) ORGANIZATION OF CENTERS.—Each center under para- graph (1) shall use the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director.
‘‘(6) NUMBER OF CENTERS; DURATION OF SUPPORT.—
‘‘(A) IN GENERAL.—The Director shall provide for the establishment of not less than five centers under paragraph
‘‘(B) DURATION.—Support for a center established
under paragraph (1) may be provided under this section for a period of not to exceed 5 years. Such period may be extended for one or more additional periods not exceeding 5 years if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended.
‘‘(c) FACILITATION OF RESEARCH.—The Director shall under sub- section (a)(1) provide for a program under which samples of tissues and genetic materials that are of use in research on autism are donated, collected, preserved, and made available for such research. The program shall be carried out in accordance with accepted scientific and medical standards for the donation, collection, and preservation of such samples.
‘‘(d) PUBLIC INPUT.—The Director shall under subsection (a)(1) provide for means through which the public can obtain information on the existing and planned programs and activities of the National Institutes of Health with respect to autism and through which the Director can receive comments from the public regarding such programs and activities.
‘‘(e) FUNDING.—There are authorized to be appropriated such sums as may be necessary to carry out this section. Amounts appropriated under this subsection are in addition to any other amounts appropriated for such purpose.’’.
SEC. 102. DEVELOPMENTAL DISABILITIES SURVEILLANCE AND 42 USC 247b–4b. RESEARCH PROGRAMS.
(a) NATIONAL AUTISM AND PERVASIVE DEVELOPMENTAL DISABIL- ITIES SURVEILLANCE PROGRAM.—
(1) IN GENERAL.—The Secretary of Health and Human Services (in this section referred to as the ‘‘Secretary’’), acting through the Director of the Centers for Disease Control and Prevention, may make awards of grants and cooperative agree- ments for the collection, analysis, and reporting of data on autism and pervasive developmental disabilities. In making such awards, the Secretary may provide direct technical assist- ance in lieu of cash.
(2) ELIGIBILITY.—To be eligible to receive an award under paragraph (1) an entity shall be a public or nonprofit private entity (including health departments of States and political subdivisions of States, and including universities and other educational entities).
(b) CENTERS OF EXCELLENCE IN AUTISM AND PERVASIVE DEVELOPMENTAL DISABILITIES EPIDEMIOLOGY.—
(1) IN GENERAL.—The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall establish not less than three regional centers of excellence in autism and pervasive developmental disabilities epidemi- ology for the purpose of collecting and analyzing information on the number, incidence, correlates, and causes of autism and related developmental disabilities.
(2) RECIPIENTS OF AWARDS FOR ESTABLISHMENT OF CEN- TERS.—Centers under paragraph (1) shall be established and operated through the awarding of grants or cooperative agree- ments to public or nonprofit private entities that conduct research, including health departments of States and political subdivisions of States, and including universities and other educational entities.
(3) CERTAIN REQUIREMENTS.—An award for a center under paragraph (1) may be made only if the entity involved submits to the Secretary an application containing such agreements and information as the Secretary may require, including an agreement that the center involved will operate in accordance with the following:
(A) The center will collect, analyze, and report autism and pervasive developmental disabilities data according to guidelines prescribed by the Director, after consultation with relevant State and local public health officials, private sector developmental disability researchers, and advocates for those with developmental disabilities.
(B) The center will assist with the development and coordination of State autism and pervasive developmental disabilities surveillance efforts within a region.
(C) The center will identify eligible cases and controls through its surveillance systems and conduct research into factors which may cause autism and related developmental disabilities.
(D) The center will develop or extend an area of special research expertise (including genetics, environmental expo- sure to contaminants, immunology, and other relevant research specialty areas).
(c) CLEARINGHOUSE.—The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall carry out the following:
(1) The Secretary shall establish a clearinghouse within the Centers for Disease Control and Prevention for the collec- tion and storage of data generated from the monitoring pro- grams established by this title. Through the clearinghouse, such Centers shall serve as the coordinating agency for autism and pervasive developmental disabilities surveillance activities. The functions of such a clearinghouse shall include facilitating the coordination of research and policy development relating to the epidemiology of autism and other pervasive develop- mental disabilities.
(2) The Secretary shall coordinate the Federal response to requests for assistance from State health department officials regarding potential or alleged autism or developmental dis- ability clusters.
(d) DEFINITION.—In this title, the term ‘‘State’’ means each
of the several States, the District of Columbia, the Commonwealth of Puerto Rico, American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, the Virgin Islands, and the Trust Territory of the Pacific Islands.
(e) AUTHORIZATION OF APPROPRIATIONS.—There are authorized to be appropriated such sums as may be necessary to carry out this section.
SEC. 103. INFORMATION AND EDUCATION.
(a) IN GENERAL.—The Secretary shall establish and implement a program to provide information and education on autism to health professionals and the general public, including information and education on advances in the diagnosis and treatment of autism and training and continuing education through programs for sci- entists, physicians, and other health professionals who provide care for patients with autism.
(b) STIPENDS.—The Secretary may use amounts made available under this section to provide stipends for health professionals who are enrolled in training programs under this section.
(c) AUTHORIZATION OF APPROPRIATIONS.—There are authorized to be appropriated such sums as may be necessary to carry out this section.
SEC. 104. INTER-AGENCY AUTISM COORDINATING COMMITTEE.
(a) ESTABLISHMENT.—The Secretary shall establish a committee to be known as the ‘‘Autism Coordinating Committee’’ (in this section referred to as the ‘‘Committee’’) to coordinate all efforts within the Department of Health and Human Services concerning autism, including activities carried out through the National Institutes of Health and the Centers for Disease Control and Prevention under this title (and the amendment made by this title).
(1) IN GENERAL.—The Committee shall be composed of the
Directors of such national research institutes, of the Centers for Disease Control and Prevention, and of such other agencies and such other officials as the Secretary determines appro- priate.
(2) ADDITIONAL MEMBERS.—If determined appropriate by the Secretary, the Secretary may appoint to the Committee— (A) parents or legal guardians of individuals with autism or other pervasive developmental disorders; and
(B) representatives of other governmental agencies that serve children with autism such as the Department of Education.
(c) ADMINISTRATIVE SUPPORT; TERMS OF SERVICE; OTHER PROVI-
SIONS.—The following shall apply with respect to the Committee: (1) The Committee shall receive necessary and appropriate administrative support from the Department of Health and Human Services.
(2) Members of the Committee appointed under subsection
(b)(2)(A) shall serve for a term of 3 years, and may serve for an unlimited number of terms if reappointed.
(3) The Committee shall meet not less than two times each year.
SEC. 105. REPORT TO CONGRESS.
Not later than January 1, 2001, and each January 1 thereafter, the Secretary shall prepare and submit to the appropriate commit- tees of Congress, a report concerning the implementation of this title and the amendments made by this title.
More With Children’s Health Act of 2000
Autistic people have fought the inclusion of ABA in therapy for us since before Autism Speaks, and other non-Autistic-led autism organizations, started lobbying legislation to get it covered by insurances and Medicaid.
ABA is a myth originally sold to parents that it would keep their Autistic child out of an institution. Today, parents are told that with early intervention therapy their child will either be less Autistic or no longer Autistic by elementary school, and can be mainstreamed in typical education classes. ABA is very expensive to pay out of pocket. Essentially, Autism Speaks has justified the big price tag up front will offset the overall burden on resources for an Autistic’s lifetime. The recommendation for this therapy is 40 hours a week for children and toddlers.
The original study that showed the success rate of ABA to be at 50% has never been replicated. In fact, the study of ABA by United States Department of Defense was denounced as a failure. Not just once, but multiple times. Simply stated: ABA doesn’t work. In study after repeated study: ABA (conversion therapy) doesn’t work.
What more recent studies do show: Autistics who experienced ABA therapy are at high risk to develop PTSD and other lifelong trauma-related conditions. Historically, the autism organizations promoting ABA as a cure or solution have silenced Autistic advocates’ opposition. ABA is also known as gay conversion therapy.
The ‘cure’ for Autistics not born yet is the prevention of birth.
The ‘cure’ is a choice to terminate a pregnancy based on ‘autism risk.’ The cure is abortion. This is the same ‘cure’ society has for Down Syndrome.
This is eugenics 2021. Instead of killing Autistics and disabled children in gas chambers or ‘mercy killings’ like in Aktion T4, it’ll happen at the doctor’s office, quietly, one Autistic baby at a time. Different approaches yes, but still eugenics and the extinction of an entire minority group of people.
Fact: You can’t cure Autistics from being Autistic.
Fact: You can’t recover an Autistic from being Autistic.
Fact: You can groom an Autistic to mask and hide their traits. Somewhat. … however, this comes at the expense of the Autistic child, promotes Autistic Burnout (this should not be confused with typical burnout, Autistic Burnout can kill Autistics), and places the Autistic child at high risk for PTSD and other lifelong trauma-related conditions.
[Note: Autism is NOT a disease, but a neurodevelopmental difference and disability.]
Fact: Vaccines Do Not Cause Autism.